Physician profile
Eric J Pappert
NPI 1710968649
$165,886.34
in general payments reported to CMS, 2019-2025
51 companies · $155K in 2025
The $155K reported for 2025 was more than what 99% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $1,343 · 2021: $1,789 · 2022: $1,967 · 2023: $3,307 · 2024: $1,840 · 2025: $155K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $154K · Food and Beverage: $6,193 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $153,988.75 |
| Food and Beverage | $6,192.90 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurotech Pharmaceuticals, INC. | $153,988.75 | 2025 | Encelto |
| Acadia Pharmaceuticals INC | $1,750.72 | 2020-2024 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $1,208.11 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Neurocrine Biosciences, INC. | $1,114.91 | 2020-2025 | Ingrezza, Ongentys |
| Abbott Laboratories | $948.60 | 2019-2025 | Infinity, Proclaim |
| Abbvie INC. | $812.33 | 2021-2025 | |
| Medtronic, INC. | $770.98 | 2021-2025 | Percept PC Brainsense, Sensight |
| Mdd US Operations, LLC | $657.84 | 2019-2025 | Gocovri, Gocovri |
| Ge Healthcare | $657.11 | 2020-2025 | |
| Acorda Therapeutics, INC | $487.00 | 2019-2024 | Inbrija |
| Neurelis, INC. | $370.75 | 2021-2025 | Valtoco |
| Ucb, INC. | $320.82 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Lilly USA, LLC | $307.92 | 2021-2024 | Amyvid, Emgality, Kisunla |
| Pfizer INC. | $190.95 | 2024-2025 | |
| Amgen INC. | $187.13 | 2020-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pappert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.